呱柏西利聯合內分泌藥物治療中國人群HR+/HER2-晚期乳腺癌的療效和安全性
曹亞兵, 陳延群, 胡皓
The efficacy and
safety of palbociclib in combination
with hormonal therapy in the
treatment of Chinese patients
with HR+/HER2- advanced stage breast cancer
CAO Ya Bing, CHEN Yan Yun, HU Hao
鏡湖醫學
.
2018, (2): 12
-15
.
